Wall Street Zen lowered shares of Hyperliquid Strategies (NASDAQ:PURR – Free Report) from a hold rating to a sell rating in a report released on Saturday,Wall Street Zen reports.
A number of other equities research analysts have also issued reports on PURR. Weiss Ratings raised Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. Cantor Fitzgerald set a $22.60 price objective on Hyperliquid Strategies and gave the company an “overweight” rating in a research report on Thursday. Finally, Chardan Capital lifted their target price on Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a “buy” rating in a research report on Friday. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.53.
Get Our Latest Research Report on Hyperliquid Strategies
Hyperliquid Strategies Price Performance
Institutional Investors Weigh In On Hyperliquid Strategies
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Boothbay Fund Management LLC bought a new position in shares of Hyperliquid Strategies during the 4th quarter worth $40,000. State of Wyoming purchased a new position in shares of Hyperliquid Strategies during the second quarter valued at $46,000. XTX Topco Ltd bought a new stake in shares of Hyperliquid Strategies in the fourth quarter valued at about $48,000. Squarepoint Ops LLC bought a new stake in shares of Hyperliquid Strategies in the fourth quarter valued at about $73,000. Finally, Shepherd Financial Partners LLC bought a new stake in shares of Hyperliquid Strategies in the second quarter valued at about $79,000. 9.45% of the stock is owned by institutional investors.
About Hyperliquid Strategies
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
See Also
- Five stocks we like better than Hyperliquid Strategies
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
